explore -WSS

explore

author：fashion 2025-09-27 10:00:36 - browse：72

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Medicare has a new plan to address drug shortages

WSS

In early work, researchers turn to CRISPR to treat Alzheimer's

The history of OxyContin, told through Purdue Pharma documents

Covid's long

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

STAT Virtual Event: The State of Biosimilars: What to Watch

How dance can help nurses traumatized by Covid

focus

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Covid's long

Cancer drug shortages should be causing more outrage

An innovative path out of biotech’s “valley of death”

Medicare proposal to cover medical devices draws a mixed reaction

TB outbreak tied to bone grafts underscores testing shortcomings

How to save PrEP access — and even expand it

A public scorecard can help hold safety

After affirmative action ruling, medical educators look to 'holistic review'

Pharma budget tightening trickles down to Doximity

explore

Sanders adds drug shortage policies to pandemic preparedness bill

Biden tests positive for Covid

In early work, researchers turn to CRISPR to treat Alzheimer's

Who are the detained American citizens released from prison in Iran?

Group opposing PBM reform sets lobbying record

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Wikipedia

hotspot

entertainment

focus